After construction delays pushed back a Dec. 1 opening, students are now beginning the new semester inside Rockport-Fulton ...
Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and ...
In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment ...
India’s second-largest IT services firm Infosys on Wednesday announced a strategic partnership with Amazon Web Services (AWS) ...
According to Renault India, the SUV was also tested in high-altitude terrains in India, including a test run in the ...
Explore the top private universities in Delhi NCR for 2026 with details on courses, fees, eligibility, admissions, placements ...
US FDA clears Ascletis’ IND application for 13-week phase II study of oral small molecule GLP-1, ASC30, in participants with diabetes: Hong Kong Wednesday, January 7, 2026, 18:0 ...
Abivax Provides 2026 Corporate Outlook New market insights indicate significant future expansion of the ulcerative colitis (UC) market, with ...
Costco is a Strong Buy after a 20% pullback, with a new target of $1,121 and fundamentals stronger than ever. Click to read ...
The proportion of higher-education faculty who are women in Taiwan has steadily increased in the past few years, but is still slightly lower than the global average, the Ministry of Education said ...
Detailed price information for Cyclerion Therapeutics Inc (CYCN-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results